MedTrace Logo

Inflammation and Acute Coronary Syndromes

NCT01000701 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2016-09-09

No results posted yet for this study

Summary

Subproject 1: Optimize prevention after acute coronary syndromes (ACS) by improving caregiver and patient education (http://elips.hug-ge.ch/eng/index\_eng2.htm)

Subproject 2: Discover novel genomic biomarkers of ACS in leukocyte subsets by means of analyzing gene expression profiles and function

Subproject 3: Evaluate novel diagnostic and prognostic biomarkers in soluble form in blood/plasma and urine

Subproject 5: Visualize the vulnerable plaque using intravascular ultrasound/optical coherence tomography (IVUS/OCT) and correlate with outcome and biomarkers

Subproject 7: Characterize the effects of inflammation on progenitor/stem cell-mediated repair after ACS by means of analyzing gene expression profiles and function

Conditions

  • Acute Coronary Syndromes

Sponsors & Collaborators

  • University of Bern

    collaborator OTHER

  • University Hospital, Geneva

    collaborator OTHER

  • University of Lausanne Hospitals

    collaborator OTHER

  • University of Zurich

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2018-01-31
Completion
2019-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01000701 on ClinicalTrials.gov